DERMOVATE

This brand name is authorized in Austria, Canada, Cyprus, Germany, Ecuador, Estonia, Hong Kong, Ireland, Israel, Japan, Lithuania, Malta, Nigeria, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug DERMOVATE contains one active pharmaceutical ingredient (API):

1 Clobetasol propionate UNII 779619577M - CLOBETASOL PROPIONATE

Clobetasol propionate, like other topical corticosteroids, has anti-inflammatory, antipruritic, and vasoconstrictive properties. Corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Read about Clobetasol propionate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DERMOVATE Scalp application	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07AD01	Clobetasol	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AD Corticosteroids, very potent (group IV)
Discover more medicines within D07AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02213265, 02213273, 02213281
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 09403981, 09403998, 15398385, 15398391
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 24.363-03-02, 24.642-08-02
Country: EE	Ravimiamet	Identifier(s): 1005208, 1005242, 1005286, 1829325, 1842386
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 138631, 142241, 142243, 161577, 161579, 19335, 19336, 19339, 19340, 19865, 19866, 377181, 377183, 377408, 377412, 377414, 394809
Country: HK	Department of Health Drug Office	Identifier(s): 06936, 06937, 30747
Country: IE	Health Products Regulatory Authority	Identifier(s): 20346, 20354, 60399, 60410, 64874, 64877, 64878
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 261, 8162, 8198
Country: JP	医薬品医療機器総合機構	Identifier(s): 2646713M1136, 2646713N1123, 2646713Q1081
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002982, 1002983, 1004082, 1061047, 1069322, 1069323, 1078134, 1079565, 1083249, 1083250, 1084599, 1084883, 1085194, 1085584, 1088379, 1088999, 1093290
Country: MT	Medicines Authority	Identifier(s): MA192/04201, MA192/04202, MA192/04203, PI908/12001B, PI908/12002B
Country: NG	Registered Drug Product Database	Identifier(s): A4-1205
Country: NL	Z-Index G-Standaard	Identifier(s): 12114669, 12355798, 12358061
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 4863, 62782
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100018050, 100018066, 100254743, 100254980, 100266120, 100266976, 100451750
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64939001, W64941001, W64943001, W64943002
Country: SG	Health Sciences Authority	Identifier(s): 04499P, 04933P, 04934P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522350711, 8699522356294, 8699522380725, 8699522386307, 8699522490738
Country: ZA	Health Products Regulatory Authority	Identifier(s): F/13.4.1/175, F/13.4.1/176, H/13.4.1/268